MBHB partner Andrew Williams, Ph.D. is a featured speaker for a presentation entitled, “Show Me the Money: Strategies to Overcome Valuation Challenges,” set for 9:00-10:15 a.m. on Nov. 3, 2017 in Philadelphia in conjunction with the ACI’s IP Due Diligence summit.
ACI is proud to introduce this one-of-a-kind, interactive forum where top diligence experts discuss best practices and strategies on how to successfully execute a proper due diligence analysis, both for your own portfolio, and that of potential targets.
Over the past few years, with many blockbuster drug patents expiring, R&D pipelines drying up, and the evolving challenges for patenting life-sciences inventions, many have coined the current landscape as “anti-patent.” As a result, there has been steady increase in companies looking to collaborate and do deals to protect their assets, maintain market share, and maximize the life of their patent portfolios.
In response to the challenging patent landscape surrounding the pharmaceutical, biotechnology, and medical device industries, ACI has pioneered a conference tailored specifically to professionals involved with intellectual property due diligence for life sciences inventions. Our IP Due Diligence Summit is a one-of-a-kind gathering place for key stakeholders to learn the best strategies and tips to map out and conduct a successful and cost-effective due diligence analysis.
You don’t want to miss out on the opportunity to participate in our interactive mock fact pattern, which will flow through the 2-day event as we address the common due diligence challenges keeping you up at night. Whether you are on the acquiring or target side, our stellar faculty will provide you with specific strategies you can immediately incorporate into your practice.